CLYDE MORRON: Open Payments
NPI 1356352298 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 64 payments from 16 companies in 2025. Trend: 2023 $1,160 · 2024 $2,286 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 19 | $262 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $211 |
| Novartis Pharmaceuticals Corporation | 6 | $145 |
| UCB, Inc. | 6 | $133 |
| Lilly USA, LLC | 4 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $70 |
| Organon LLC | 5 | $59 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $55 |
| Krystal Biotech Inc | 2 | $47 |
Products named: OPZELURA, ILUMYA, Bimzelx, COSENTYX, TALTZ, JOURNAVX, DUPIXENT, Zoryve.
Industry payments across TX — which companies pay providers there.
